Advertisement

Phytochemistry Reviews

, Volume 14, Issue 6, pp 933–959 | Cite as

Protection of pancreatic β-cell function by dietary polyphenols

  • Margherita Dall’Asta
  • Morgane Bayle
  • Jérémie Neasta
  • Francesca Scazzina
  • Renato Bruni
  • Gérard Cros
  • Daniele Del RioEmail author
  • Catherine Oiry
Article
First Online:

Abstract

Diabetes mellitus is a complex metabolic disorder and is considered a fast-growing global health problem. Type 2 diabetes (T2D) represents the majority of total diabetes prevalence and β-cell dysfunction has been described as a crucial point for this disease development and progression. To date, all of the common anti-hyperglycaemic drugs used for diabetes management cause undesirable side effects or problems with long-term efficacy or safety and the development of alternative approaches for the prevention as well as for the treatment of T2D might be a valuable solution to meet this rising demand. In this regards, numerous epidemiological studies indicate that exposure to certain polyphenol compounds is associated with the prevention of chronic diseases, including diabetes. Here, we review growing evidence suggesting that polyphenols can modulate the activity of various molecular targets, which are known to control β-cell function, involved in the development and the progression of this diabetes. The protective effects of polyphenols on β-cell function is reported with a particular focus on the mechanism of action behind polyphenol putative bioactivity. Animal and in vitro studies selected in this review, reporting about both flavonoid and non-flavonoid compounds, highlight the direct action of polyphenols on pancreatic β-cells, stimulating insulin secretion through the activation of specific cellular targets and protecting these cells from damages mediated by oxidative stress and inflammation, both typically elevated in diabetes. Some of the reviewed studies describe polyphenol effects comparable to those exerted by many drugs commonly used in diabetes treatment, and, in some occasions, synergistic polyphenol-drug interactions. Finally, future studies need to be addressed to the effects of specific polyphenol human and microbial metabolites, which are still poorly studied, in order to better define the preventive and therapeutic approach to contrast β-cell failure and diabetes progression.

Keywords

β-cell protection Diabetes Flavonoids Insulin secretion 
This is a preview of subscription content, log in to check access.

References

  1. Adewole SO, Caxton-Martins EA, Ojewole JA (2006) Protective effect of quercetin on the morphology of pancreatic beta-cells of streptozotocin-treated diabetic rats. Afr J Tradit Complement Altern Med 4:64–74PubMedCentralPubMedGoogle Scholar
  2. Adisakwattana S, Moonsan P, Yibchok-Anun S (2008) Insulin-releasing properties of a series of cinnamic acid derivatives in vitro and in vivo. J Agric Food Chem 56:7838–7844PubMedCrossRefGoogle Scholar
  3. Ae Park S, Choi MS, Cho SY et al (2006) Genistein and daidzein modulate hepatic glucose and lipid regulating enzyme activities in C57BL/KsJ-db/db mice. Life Sci 79:1207–1213PubMedCrossRefGoogle Scholar
  4. Al-Numair KS, Chandramohan G, Veeramani C et al (2014) Ameliorative effect of kaempferol, a flavonoid, on oxidative stress in streptozotocin-induced diabetic rats. Redox Rep. doi: 10.1179/1351000214Y.0000000117 PubMedGoogle Scholar
  5. Annadurai T, Muralidharan AR, Joseph T et al (2012) Antihyperglycemic and antioxidant effects of a flavanone, naringenin, in streptozotocin-nicotinamide-induced experimental diabetic rats. J Physiol Biochem 68:307–318PubMedCrossRefGoogle Scholar
  6. Annadurai T, Thomas PA, Geraldine P (2013) Ameliorative effect of naringenin on hyperglycemia-mediated inflammation in hepatic and pancreatic tissues of Wistar rats with streptozotocin-nicotinamide-induced experimental diabetes mellitus. Free Radic Res 47:793–803PubMedCrossRefGoogle Scholar
  7. Aron PM, Kennedy JA (2008) Flavan-3-ols: nature, occurrence and biological activity. Mol Nutr Food Res 52:79–104PubMedCrossRefGoogle Scholar
  8. Ashcroft FM, Rorsman P (2004) Molecular defects in insulin secretion in type-2 diabetes. Rev Endocr Metab Disord 5:135–142PubMedCrossRefGoogle Scholar
  9. Babu PV, Liu D, Gilbert ER (2013) Recent advances in understanding the anti-diabetic actions of dietary flavonoids. J Nutr Biochem 24:1777–1789PubMedCrossRefGoogle Scholar
  10. Bahadoran Z, Mirmiran P, Azizi F (2013) Dietary polyphenols as potential nutraceuticals in management of diabetes: a review. J Diabetes Metab Disord 12:43PubMedCentralPubMedCrossRefGoogle Scholar
  11. Bardy G, Virsolvy A, Quignard JF et al (2013) Quercetin induces insulin secretion by direct activation of L-type calcium channels in pancreatic beta cells. Br J Pharmacol 169:1102–1113PubMedCentralPubMedCrossRefGoogle Scholar
  12. Behloul N, Wu G (2013) Genistein: a promising therapeutic agent for obesity and diabetes treatment. Eur J Pharmacol 698:31–38PubMedCrossRefGoogle Scholar
  13. Bensellam M, Laybutt DR, Jonas JC (2012) The molecular mechanisms of pancreatic beta-cell glucotoxicity: recent findings and future research directions. Mol Cell Endocrinol 364:1–27PubMedCrossRefGoogle Scholar
  14. Bhakkiyalakshmi E, Shalini D, Sekar TV et al (2014) Therapeutic potential of pterostilbene against pancreatic beta-cell apoptosis mediated through Nrf2. Br J Pharmacol 171:1747–1757PubMedCentralPubMedCrossRefGoogle Scholar
  15. Bhattacharya S, Oksbjerg N, Young JF et al (2014) Caffeic acid, naringenin and quercetin enhance glucose-stimulated insulin secretion and glucose sensitivity in INS-1E cells. Diabetes Obes Metab 16:602–612PubMedCrossRefGoogle Scholar
  16. Bonora E (2008) Protection of pancreatic beta-cells: is it feasible? Nutr Metab Cardiovasc Dis 18:74–83PubMedCrossRefGoogle Scholar
  17. Briaud I, Lingohr MK, Dickson LM et al (2003) Differential activation mechanisms of Erk-1/2 and p70(S6K) by glucose in pancreatic beta-cells. Diabetes 52:974–983PubMedCrossRefGoogle Scholar
  18. Brunzell JD, Robertson RP, Lerner RL et al (1976) Relationships between fasting plasma glucose levels and insulin secretion during intravenous glucose tolerance tests. J Clin Endocrinol Metab 42:222–229PubMedCrossRefGoogle Scholar
  19. Cai EP, Lin JK (2009) Epigallocatechin gallate (EGCG) and rutin suppress the glucotoxicity through activating IRS2 and AMPK signaling in rat pancreatic beta cells. J Agric Food Chem 57:9817–9827PubMedCrossRefGoogle Scholar
  20. Cao Y, Bao S, Yang W et al (2014) Epigallocatechin gallate prevents inflammation by reducing macrophage infiltration and inhibiting tumor necrosis factor-alpha signaling in the pancreas of rats on a high-fat diet. Nutr Res 34:1066–1074PubMedCrossRefGoogle Scholar
  21. Chaturvedi N (2007) The burden of diabetes and its complications: trends and implications for intervention. Diabetes Res Clin Pract 76(Suppl 1):S3–12PubMedCrossRefGoogle Scholar
  22. Chen WP, Chi TC, Chuang LM et al (2007) Resveratrol enhances insulin secretion by blocking K(ATP) and K(V) channels of beta cells. Eur J Pharmacol 568:269–277PubMedCrossRefGoogle Scholar
  23. Chiasson JL, Josse RG, Gomis R et al (2002) Acarbose for prevention of type 2 diabetes mellitus: the STOP-NIDDM randomised trial. Lancet 359:2072–2077PubMedCrossRefGoogle Scholar
  24. Cho JM, Chang SY, Kim DB et al (2012) Effects of physiological quercetin metabolites on interleukin-1beta-induced inducible NOS expression. J Nutr Biochem 23:1394–1402PubMedCrossRefGoogle Scholar
  25. Choi MS, Jung UJ, Yeo J et al (2008) Genistein and daidzein prevent diabetes onset by elevating insulin level and altering hepatic gluconeogenic and lipogenic enzyme activities in non-obese diabetic (NOD) mice. Diabetes Metab Res Rev 24:74–81PubMedCrossRefGoogle Scholar
  26. Clifford MN (2000) Anthocyanins—nature, occurrence and dietary burden. J Sci Food Agric 80:1063–1072CrossRefGoogle Scholar
  27. Coskun O, Kanter M, Korkmaz A et al (2005) Quercetin, a flavonoid antioxidant, prevents and protects streptozotocin-induced oxidative stress and beta-cell damage in rat pancreas. Pharmacol Res 51:117–123PubMedCrossRefGoogle Scholar
  28. Costes S, Broca C, Bertrand G et al (2006) ERK1/2 control phosphorylation and protein level of cAMP-responsive element-binding protein: a key role in glucose-mediated pancreatic beta-cell survival. Diabetes 55:2220–2230PubMedCrossRefGoogle Scholar
  29. Coward L, Smith M, Kirk M et al (1998) Chemical modification of isoflavones in soyfoods during cooking and processing. Am J Clin Nutr 68:1486S–1491SPubMedGoogle Scholar
  30. Crozier A, Jaganath IB, Clifford MN (2009) Dietary phenolics: chemistry, bioavailability and effects on health. Natural Product Reports 26:1001–1043PubMedCrossRefGoogle Scholar
  31. Crozier A, Del Rio D, Clifford MN (2010) Bioavailability of dietary flavonoids and phenolic compounds. Mol Aspects Med 31:446–467PubMedCrossRefGoogle Scholar
  32. Dai X, Ding Y, Zhang Z et al (2013) Quercetin and quercitrin protect against cytokineinduced injuries in RINm5F beta-cells via the mitochondrial pathway and NF-kappaB signaling. Int J Mol Med 31:265–271PubMedGoogle Scholar
  33. Dalle S, Burcelin R, Gourdy P (2013) Specific actions of GLP-1 receptor agonists and DPP4 inhibitors for the treatment of pancreatic beta-cell impairments in type 2 diabetes. Cell Signal 25:570–579PubMedCrossRefGoogle Scholar
  34. Day AJ, Canada FJ, Diaz JC et al (2000) Dietary flavonoid and isoflavone glycosides are hydrolysed by the lactase site of lactase phlorizin hydrolase. FEBS Lett 468:166–170PubMedCrossRefGoogle Scholar
  35. Del Prato S, Tiengo A (2001) The importance of first-phase insulin secretion: implications for the therapy of type 2 diabetes mellitus. Diabetes Metab Res Rev 17:164–174PubMedCrossRefGoogle Scholar
  36. Del Rio D, Costa LG, Lean ME et al (2010) Polyphenols and health: what compounds are involved? Nutr Metab Cardiovasc Dis 20:1–6PubMedCrossRefGoogle Scholar
  37. Del Rio D, Rodriguez-Mateos A, Spencer JP et al (2013) Dietary (poly)phenolics in human health: structures, bioavailability, and evidence of protective effects against chronic diseases. Antioxid Redox Signal 18:1818–1892PubMedCentralPubMedCrossRefGoogle Scholar
  38. Do GM, Jung UJ, Park HJ et al (2012) Resveratrol ameliorates diabetes-related metabolic changes via activation of AMP-activated protein kinase and its downstream targets in db/db mice. Mol Nutr Food Res 56:1282–1291PubMedCrossRefGoogle Scholar
  39. Donovan JL, Manach C, Faulks RM et al (2006) Absorption and metabolism of dietary plant secondary metabolites. In: Crozier A, Clifford MN, Ashinara H (eds) Plant secondary metabolites: occurrence, structure and role in the human diet. Blackwell Publishing, Oxford, pp 303–351Google Scholar
  40. Drews G, Krippeit-Drews P, Dufer M (2010) Oxidative stress and beta-cell dysfunction. Pflugers Arch 460:703–718PubMedCrossRefGoogle Scholar
  41. Elmarakby AA, Ibrahim AS, Faulkner J et al (2011) Tyrosine kinase inhibitor, genistein, reduces renal inflammation and injury in streptozotocin-induced diabetic mice. Vascul Pharmacol 55:149–156PubMedCrossRefGoogle Scholar
  42. Fernandez-Millan E, Ramos S, Alvarez C et al (2014) Microbial phenolic metabolites improve glucose-stimulated insulin secretion and protect pancreatic beta cells against tert-butyl hydroperoxide-induced toxicity via ERKs and PKC pathways. Food Chem Toxicol 66:245–253PubMedCrossRefGoogle Scholar
  43. Forouhi NG, Wareham NJ (2010) Epidemiology of diabetes. Medicine 38:602–606CrossRefGoogle Scholar
  44. Frodin M, Sekine N, Roche E et al (1995) Glucose, other secretagogues, and nerve growth factor stimulate mitogen-activated protein kinase in the insulin-secreting beta-cell line, INS-1. J Biol Chem 270:7882–7889PubMedCrossRefGoogle Scholar
  45. Fu Z, Zhang W, Zhen W et al (2010) Genistein induces pancreatic beta-cell proliferation through activation of multiple signaling pathways and prevents insulin-deficient diabetes in mice. Endocrinology 151:3026–3037PubMedCentralPubMedCrossRefGoogle Scholar
  46. Fu Z, Zhen W, Yuskavage J et al (2011) Epigallocatechin gallate delays the onset of type 1 diabetes in spontaneous non-obese diabetic mice. Br J Nutr 105:1218–1225PubMedCentralPubMedCrossRefGoogle Scholar
  47. Fu Z, Gilbert ER, Pfeiffer L et al (2012) Genistein ameliorates hyperglycemia in a mouse model of nongenetic type 2 diabetes. Appl Physiol Nutr Metab 37:480–488PubMedCentralPubMedCrossRefGoogle Scholar
  48. Fu Z, Yuskavage J, Liu D (2013) Dietary flavonol epicatechin prevents the onset of type 1 diabetes in nonobese diabetic mice. J Agric Food Chem 61:4303–4309PubMedCentralPubMedCrossRefGoogle Scholar
  49. Gee JM, DuPont MS, Day AJ et al (2000) Intestinal transport of quercetin glycosides in rats involves both deglycosylation and interaction with the hexose transport pathway. J Nutr 130:2765–2771PubMedGoogle Scholar
  50. Gharib A, Faezizadeh Z, Godarzee M (2013) Treatment of diabetes in the mouse model by delphinidin and cyanidin hydrochloride in free and liposomal forms. Planta Med 79:1599–1604PubMedCrossRefGoogle Scholar
  51. Gilbert ER, Liu D (2013) Anti-diabetic functions of soy isoflavone genistein: mechanisms underlying its effects on pancreatic beta-cell function. Food Funct 4:200–212PubMedCentralPubMedCrossRefGoogle Scholar
  52. Gu L, Kelm MA, Hammerstone JF et al (2004) Concentrations of proanthocyanidins in common foods and estimations of normal consumption. J Nutr 134:613–617PubMedGoogle Scholar
  53. Habtemariam S, Varghese GK (2014) The antidiabetic therapeutic potential of dietary polyphenols. Curr Pharm Biotechnol 15:391–400PubMedCrossRefGoogle Scholar
  54. Han MK (2003) Epigallocatechin gallate, a constituent of green tea, suppresses cytokine-induced pancreatic beta-cell damage. Exp Mol Med 35:136–139PubMedCrossRefGoogle Scholar
  55. Hanhineva K, Torronen R, Bondia-Pons I et al (2010) Impact of dietary polyphenols on carbohydrate metabolism. Int J Mol Sci 11:1365–1402PubMedCentralPubMedCrossRefGoogle Scholar
  56. Hartley L, Igbinedion E, Holmes J et al. (2013) Increased consumption of fruit and vegetables for the primary prevention of cardiovascular diseases. Cochrane Database Syst Rev 6:CD009874Google Scholar
  57. Hirota S, Nishioka T, Shimoda T et al (2001) Quercetin glucosides are hydrolyzed to quercetin in human oral cavity to participate in peroxidase-dependent scavenging of hydrogen peroxide. Food Sci Technol Res 7:239–245CrossRefGoogle Scholar
  58. Ishisaka A, Kawabata K, Miki S et al (2013) Mitochondrial dysfunction leads to deconjugation of quercetin glucuronides in inflammatory macrophages. PLoS ONE 8:e80843PubMedCentralPubMedCrossRefGoogle Scholar
  59. Jayaprakasam B, Vareed SK, Olson LK et al (2005) Insulin secretion by bioactive anthocyanins and anthocyanidins present in fruits. J Agric Food Chem 53:28–31PubMedCrossRefGoogle Scholar
  60. Jeong SM, Kang MJ, Choi HN et al (2012) Quercetin ameliorates hyperglycemia and dyslipidemia and improves antioxidant status in type 2 diabetic db/db mice. Nutr Res Pract 6:201–207PubMedCentralPubMedCrossRefGoogle Scholar
  61. Jung UJ, Lee MK, Park YB et al (2006) Antihyperglycemic and antioxidant properties of caffeic acid in db/db mice. J Pharmacol Exp Ther 318:476–483PubMedCrossRefGoogle Scholar
  62. Kaneko YK, Takii M, Kojima Y et al (2015) Structure-dependent inhibitory effects of green tea catechins on insulin secretion from pancreatic beta-cells. Biol Pharm Bull 38:476–481PubMedCrossRefGoogle Scholar
  63. Kawai Y, Nishikawa T, Shiba Y et al (2008) Macrophage as a target of quercetin glucuronides in human atherosclerotic arteries: implication in the anti-atherosclerotic mechanism of dietary flavonoids. J Biol Chem 283:9424–9434PubMedCrossRefGoogle Scholar
  64. Kim EK, Kwon KB, Song MY et al (2007a) Flavonoids protect against cytokine-induced pancreatic β-cell damage through suppression of nuclear factor κB activation. Pancreas 35:e1–e9PubMedCrossRefGoogle Scholar
  65. Kim EK, Kwon KB, Song MY et al (2007b) Genistein protects pancreatic beta cells against cytokine-mediated toxicity. Mol Cell Endocrinol 278:18–28PubMedCrossRefGoogle Scholar
  66. Kim MK, Jung HS, Yoon CS et al (2010) EGCG and quercetin protected INS-1 cells in oxidative stress via different mechanisms. Front Biosci (Elite Ed) 2:810–817CrossRefGoogle Scholar
  67. Kim JH, Kang MJ, Choi HN et al (2011) Quercetin attenuates fasting and postprandial hyperglycemia in animal models of diabetes mellitus. Nutr Res Pract 5:107–111PubMedCentralPubMedCrossRefGoogle Scholar
  68. Knowler WC, Barrett-Connor E, Fowler SE et al (2002) Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 346:393–403PubMedCrossRefGoogle Scholar
  69. Knowler WC, Hamman RF, Edelstein SL et al (2005) Prevention of type 2 diabetes with troglitazone in the Diabetes Prevention Program. Diabetes 54:1150–1156PubMedCrossRefGoogle Scholar
  70. Knutson KL, Hoenig M (1994) Identification and subcellular characterization of protein kinase-C isoforms in insulinoma beta-cells and whole islets. Endocrinology 135:881–886PubMedGoogle Scholar
  71. Kobori M, Masumoto S, Akimoto Y, Takahashi Y (2009) Dietary quercetin alleviates diabetic symptoms and reduces streptozotocin-induced disturbance of hepatic gene expression in mice. Mol Nutr Food Res 53:859–868PubMedCrossRefGoogle Scholar
  72. Ku CR, Lee HJ, Kim SK et al (2012) Resveratrol prevents streptozotocin-induced diabetes by inhibiting the apoptosis of pancreatic beta-cell and the cleavage of poly (ADP-ribose) polymerase. Endocr J 59:103–109PubMedCrossRefGoogle Scholar
  73. Landete JM (2011) Ellagitannins, ellagic acid and their derived metabolites: a review about source, metabolism, functions and health. Food Res Int 44:1150–1160CrossRefGoogle Scholar
  74. Lee JS (2006) Effects of soy protein and genistein on blood glucose, antioxidant enzyme activities, and lipid profile in streptozotocin-induced diabetic rats. Life Sci 79:1578–1584PubMedCrossRefGoogle Scholar
  75. Lee MJ, Lambert JD, Prabhu S et al (2004) Delivery of tea polyphenols to the oral cavity by green tea leaves and black tea extract. Cancer Epidemiol Biomark Prev 13:132–137CrossRefGoogle Scholar
  76. Lee JH, Song MY, Song EK et al (2009a) Overexpression of SIRT1 protects pancreatic β-cells against cytokine toxicity by suppressing the nuclear factor-κB signaling pathway. Diabetes 58:344–351PubMedCentralPubMedCrossRefGoogle Scholar
  77. Lee SJ, Kim HE, Choi SE et al (2009b) Involvement of Ca2+/calmodulin kinase II (CaMK II) in genistein-induced potentiation of leucine/glutamine-stimulated insulin secretion. Mol Cells 28:167–174PubMedCrossRefGoogle Scholar
  78. Lee YE, Kim JW, Lee EM et al (2012) Chronic resveratrol treatment protects pancreatic islets against oxidative stress in db/db mice. PLoS ONE 7:e50412PubMedCentralPubMedCrossRefGoogle Scholar
  79. Li JM, Wang W, Fan CY et al (2013) Quercetin preserves beta-cell mass and function in fructose-induced hyperinsulinemia through modulating pancreatic Akt/FoxO1 activation. Evid Based Complement Alternat Med 2013:303902PubMedCentralPubMedGoogle Scholar
  80. Lin CY, Ni CC, Yin MC et al (2012) Flavonoids protect pancreatic beta-cells from cytokines mediated apoptosis through the activation of PI3-kinase pathway. Cytokine 59:65–71PubMedCrossRefGoogle Scholar
  81. Lindstrom J, Ilanne-Parikka P, Peltonen M et al (2006) Sustained reduction in the incidence of type 2 diabetes by lifestyle intervention: follow-up of the Finnish Diabetes Prevention Study. Lancet 368:1673–1679PubMedCrossRefGoogle Scholar
  82. Liu D, Zhen W, Yang Z et al (2006) Genistein acutely stimulates insulin secretion in pancreatic beta-cells through a cAMP-dependent protein kinase pathway. Diabetes 55:1043–1050PubMedCrossRefGoogle Scholar
  83. Longuet C, Broca C, Costes S et al (2005) Extracellularly regulated kinases 1/2 (p44/42 mitogen-activated protein kinases) phosphorylate synapsin I and regulate insulin secretion in the MIN6 beta-cell line and islets of Langerhans. Endocrinology 146:643–654PubMedCrossRefGoogle Scholar
  84. Mahmoud AM, Ashour MB, Abdel-Moneim A et al (2012) Hesperidin and naringin attenuate hyperglycemia-mediated oxidative stress and proinflammatory cytokine production in high fat fed/streptozotocin-induced type 2 diabetic rats. J Diabetes Complications 26:483–490PubMedCrossRefGoogle Scholar
  85. Manach C, Williamson G, Morand C et al (2005) Bioavailability and bioefficacy of polyphenols in humans. I. Review of 97 bioavailability studies. Am J Clin Nutr 81:230S–242SPubMedGoogle Scholar
  86. Marchetti P, Dotta F, Lauro D et al (2008) An overview of pancreatic beta-cell defects in human type 2 diabetes: implications for treatment. Regul Pept 146:4–11PubMedCrossRefGoogle Scholar
  87. Martin MA, Fernandez-Millan E, Ramos S et al (2014) Cocoa flavonoid epicatechin protects pancreatic beta cell viability and function against oxidative stress. Mol Nutr Food Res 58:447–456PubMedCrossRefGoogle Scholar
  88. Mears D (2004) Regulation of insulin secretion in islets of Langerhans by Ca(2+)channels. J Membr Biol 200:57–66PubMedCrossRefGoogle Scholar
  89. Mena P, Garcia-Viguera C, Navarro-Rico J et al (2011) Phytochemical characterisation for industrial use of pomegranate (Punica granatum L.) cultivars grown in Spain. J Sci Food Agric 91:1893–1906PubMedCrossRefGoogle Scholar
  90. Neveu V, Perez-Jimenez J, Vos F et al (2010) Phenol-explorer: an online comprehensive database on polyphenol contents in foods. Database 2010:bap024Google Scholar
  91. Ock KC, Sang JC, Song WO (2007) Estimated dietary flavonoid intake and major food sources of U.S. adults. J Nutr 137:1244–1252Google Scholar
  92. Palsamy P, Subramanian S (2010) Ameliorative potential of resveratrol on proinflammatory cytokines, hyperglycemia mediated oxidative stress, and pancreatic beta-cell dysfunction in streptozotocin-nicotinamide-induced diabetic rats. J Cell Physiol 224:423–432PubMedCrossRefGoogle Scholar
  93. Panda S, Kar A (2007) Apigenin (4′,5,7-trihydroxyflavone) regulates hyperglycaemia, thyroid dysfunction and lipid peroxidation in alloxan-induced diabetic mice. J Pharm Pharmacol 59:1543–1548PubMedCrossRefGoogle Scholar
  94. Pinent M, Castell A, Baiges I et al (2008) Bioactivity of flavonoids on insulin-secreting cells. Compr Rev Food Sci Food Saf 7:299–308CrossRefGoogle Scholar
  95. Poitout V, Robertson RP (2008) Glucolipotoxicity: fuel excess and beta-cell dysfunction. Endocr Rev 29:351–366 PubMedCentralPubMedCrossRefGoogle Scholar
  96. Prabhakar PK, Prasad R, Ali S, et al (2013) Synergistic interaction of ferulic acid with commercial hypoglycemic drugs in streptozotocin induced diabetic rats. Phytomedicine 20:488–494PubMedCrossRefGoogle Scholar
  97. Prasath GS, Sundaram CS, Subramanian SP (2013) Fisetin averts oxidative stress in pancreatic tissues of streptozotocin-induced diabetic rats. Endocrine 44:359–368PubMedCrossRefGoogle Scholar
  98. Punithavathi VR, Prince PS, Kumar R et al (2011) Antihyperglycaemic, antilipid peroxidative and antioxidant effects of gallic acid on streptozotocin induced diabetic Wistar rats. Eur J Pharmacol 650:465–471PubMedCrossRefGoogle Scholar
  99. Rahier J, Guiot Y, Goebbels RM et al (2008) Pancreatic beta-cell mass in European subjects with type 2 diabetes. Diabetes Obes Metab 10(Suppl 4):32–42PubMedCrossRefGoogle Scholar
  100. Ramar M, Manikandan B, Raman T et al (2012) Protective effect of ferulic acid and resveratrol against alloxan-induced diabetes in mice. Eur J Pharmacol 690:226–235PubMedCrossRefGoogle Scholar
  101. Rauter AP, Martins A, Borges C et al (2010) Antihyperglycaemic and protective effects of flavonoids on streptozotocin-induced diabetic rats. Phytother Res 24:S133–S138PubMedCrossRefGoogle Scholar
  102. Rodriguez-Mateos A, Vauzour D, Krueger CG et al (2014) Bioavailability, bioactivity and impact on health of dietary flavonoids and related compounds: an update. Arch Toxicol 88:1803–1853PubMedCrossRefGoogle Scholar
  103. Rouse M, Younès A, Egan JM (2014) Resveratrol and curcumin enhance pancreatic β-cell function by inhibiting phosphodiesterase activity. J Endocrinol 223:107–117PubMedCentralPubMedCrossRefGoogle Scholar
  104. Roy M, Sen S, Chakraborti AS (2008) Action of pelargonidin on hyperglycemia and oxidative damage in diabetic rats: implication for glycation-induced hemoglobin modification. Life Sci 82:1102–1110PubMedCrossRefGoogle Scholar
  105. Roy S, Metya SK, Sannigrahi S et al (2013) Treatment with ferulic acid to rats with streptozotocin-induced diabetes: effects on oxidative stress, pro-inflammatory cytokines, and apoptosis in the pancreatic β cell. Endocrine 44:369–379PubMedCrossRefGoogle Scholar
  106. Sala R, Mena P, Savi M et al (2015) Urolithins at physiological concentrations affect the levels of pro-inflammatory cytokines and growth factor in cultured cardiac cells in hyperglucidic conditions. J Funct Foods 15:97–105CrossRefGoogle Scholar
  107. Sameermahmood Z, Raji L, Saravanan T et al (2010) Gallic acid protects RINm5F beta-cells from glucolipotoxicity by its antiapoptotic and insulin-secretagogue actions. Phytother Res 24(Suppl 1):S83–94PubMedCrossRefGoogle Scholar
  108. Sartor G, Schersten B, Carlstrom S et al (1980) Ten-year follow-up of subjects with impaired glucose tolerance: prevention of diabetes by tolbutamide and diet regulation. Diabetes 29:41–49PubMedCrossRefGoogle Scholar
  109. Scalbert A, Manach C, Morand C et al (2005) Dietary polyphenols and the prevention of diseases. Crit Rev Food Sci Nutr 45:287–306PubMedCrossRefGoogle Scholar
  110. Scully T (2012) Diabetes in numbers. Nature 485:S2–S3PubMedCrossRefGoogle Scholar
  111. Selma MV, Espin JC, Tomas-Barberan FA (2009) Interaction between phenolics and gut microbiota: role in human health. J Agric Food Chem 57:6485–6501PubMedCrossRefGoogle Scholar
  112. Sharma AK, Bharti S, Ojha S et al (2011) Up-regulation of PPARγ, heat shock protein-27 and-72 by naringin attenuates insulin resistance, β-cell dysfunction, hepatic steatosis and kidney damage in a rat model of type 2 diabetes. Br J Nutr 106:1713–1723PubMedCrossRefGoogle Scholar
  113. Shaw JE, Sicree RA, Zimmet PZ (2010) Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Res Clin Pract 87:4–14PubMedCrossRefGoogle Scholar
  114. Song EK, Hur H, Han MK (2003) Epigallocatechin gallate prevents autoimmune diabetes induced by multiple low doses of streptozotocin in mice. Arch Pharm Res 26:559–563PubMedCrossRefGoogle Scholar
  115. Sorenson RL, Brelje TC, Roth C (1994) Effect of tyrosine kinase inhibitors on islets of Langerhans: evidence for tyrosine kinases in the regulation of insulin secretion. Endocrinology 134:1975–1978PubMedGoogle Scholar
  116. Suh KS, Chon S, Oh S et al (2010) Prooxidative effects of green tea polyphenol (-)-epigallocatechin-3-gallate on the HIT-T15 pancreatic beta cell line. Cell Biol Toxicol 26:189–199PubMedCrossRefGoogle Scholar
  117. Suh KS, Oh S, Woo JT et al (2012) Apigenin attenuates 2-deoxy-D-ribose-induced oxidative cell damage in HIT-T15 pancreatic β-cells. Biol Pharm Bull 35:121–126PubMedCrossRefGoogle Scholar
  118. Szkudelski T (2006) Resveratrol inhibits insulin secretion from rat pancreatic islets. Eur J Pharmacol 552:176–181PubMedCrossRefGoogle Scholar
  119. Szkudelski T (2008) The insulin-suppressive effect of resveratrol—an in vitro and in vivo phenomenon. Life Sci 82:430–435PubMedCrossRefGoogle Scholar
  120. Szkudelski T, Szkudelska K (2015) Resveratrol and diabetes: from animal to human studies. Biochim Biophys Acta 1852:1145-1154PubMedCrossRefGoogle Scholar
  121. Tuomilehto J, Lindstrom J, Eriksson JG et al (2001) Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med 344:1343–1350PubMedCrossRefGoogle Scholar
  122. Vessal M, Hemmati M, Vasei M (2003) Antidiabetic effects of quercetin in streptozocin-induced diabetic rats. Comp Biochem Physiol C Toxicol Pharmacol 135C:357–364PubMedCrossRefGoogle Scholar
  123. Vetterli L, Brun T, Giovannoni L et al (2011) Resveratrol potentiates glucose-stimulated insulin secretion in INS-1E β-cells and human islets through a SIRT1-dependent mechanism. J Biol Chem 286:6049–6060PubMedCentralPubMedCrossRefGoogle Scholar
  124. Walle T, Browning AM, Steed LL et al (2005) Flavonoid glucosides are hydrolyzed and thus activated in the oral cavity in humans. J Nutr 135:48–52PubMedGoogle Scholar
  125. Wang X, Ouyang Y, Liu J et al (2014) Fruit and vegetable consumption and mortality from all causes, cardiovascular disease, and cancer: systematic review and dose-response meta-analysis of prospective cohort studies. BMJ 349:g4490PubMedCentralPubMedCrossRefGoogle Scholar
  126. Wenham RM, Landt M, Easom RA (1994) Glucose activates the multifunctional Ca2+/calmodulin-dependent protein kinase II in isolated rat pancreatic islets. J Biol Chem 269:4947–4952PubMedGoogle Scholar
  127. Whalen K, Miller S, Onge ES (2015) The role of sodium-glucose co-transporter 2 inhibitors in the treatment of Type 2 diabetes. Clin Ther 37:1150-1166Google Scholar
  128. Whiting DR, Guariguata L, Weil C et al (2011) IDF diabetes atlas: global estimates of the prevalence of diabetes for 2011 and 2030. Diabetes Res Clin Pract 94:311–321PubMedCrossRefGoogle Scholar
  129. Williamson G (2013) Possible effects of dietary polyphenols on sugar absorption and digestion. Mol Nutr Food Res 57:48–57PubMedCrossRefGoogle Scholar
  130. Wollheim CB, Sharp GW (1981) Regulation of insulin release by calcium. Physiol Rev 61:914–973PubMedGoogle Scholar
  131. Wu X, Beecher GR, Holden JM et al (2006) Concentrations of anthocyanins in common foods in the United States and estimation of normal consumption. J Agric Food Chem 54:4069–4075PubMedCrossRefGoogle Scholar
  132. Youl E, Bardy G, Magous R et al (2010) Quercetin potentiates insulin secretion and protects INS-1 pancreatic beta-cells against oxidative damage via the ERK1/2 pathway. Br J Pharmacol 161:799–814PubMedCentralPubMedCrossRefGoogle Scholar
  133. Youl E, Magous R, Cros G et al (2014) MAP Kinase cross talks in oxidative stress-induced impairment of insulin secretion. Involvement in the protective activity of quercetin. Fundam Clin Pharmacol 28:608–615PubMedCrossRefGoogle Scholar
  134. Yun SY, Kim SP, Song DK (2006) Effects of (-)-epigallocatechin-3-gallate on pancreatic beta-cell damage in streptozotocin-induced diabetic rats. Eur J Pharmacol 541:115–121PubMedCrossRefGoogle Scholar
  135. Zamora-Ros R, Andres-Lacueva C, Lamuela-Raventos RM et al (2008) Concentrations of resveratrol and derivatives in foods and estimation of dietary intake in a Spanish population: European Prospective Investigation into Cancer and Nutrition (EPIC)-Spain cohort. Br J Nutr 100:188–196PubMedCrossRefGoogle Scholar
  136. Zanotti I, Dall’Asta M, Mena P et al (2015) Atheroprotective effects of (poly)phenols: a focus on cell cholesterol metabolism. Food Funct 6:13–31PubMedCrossRefGoogle Scholar
  137. Zhang Y, Liu D (2011) Flavonol kaempferol improves chronic hyperglycemia-impaired pancreatic beta-cell viability and insulin secretory function. Eur J Pharmacol 670:325–332PubMedCrossRefGoogle Scholar
  138. Zhang Z, Ding Y, Dai X et al (2011) Epigallocatechin-3-gallate protects pro-inflammatory cytokine induced injuries in insulin-producing cells through the mitochondrial pathway. Eur J Pharmacol 670:311–316PubMedCrossRefGoogle Scholar
  139. Zhang J, Chen L, Zheng J et al (2012) The protective effect of resveratrol on islet insulin secretion and morphology in mice on a high-fat diet. Diabetes Res Clin Pract 97:474–482PubMedCrossRefGoogle Scholar
  140. Zhang Y, Zhen W, Maechler P et al (2013) Small molecule kaempferol modulates PDX-1 protein expression and subsequently promotes pancreatic beta-cell survival and function via CREB. J Nutr Biochem 24:638–646PubMedCentralPubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media Dordrecht 2015

Authors and Affiliations

  1. 1.LS9 Interlab Group, The Laboratory of Phytochemicals in Physiology, Human Nutrition Unit, Department of Food ScienceUniversity of Parma, Medical SchoolParmaItaly
  2. 2.Institut des Biomolécules Max Mousseron (IBMM)UMR 5247 CNRS-Université de Montpellier-ENSCMMontpellier Cedex 5France
  3. 3.Department of Food ScienceUniversity of Parma, Medical SchoolParmaItaly
  4. 4.The Need for Nutrition Education/Innovation Programme (NNEdPro)University of CambridgeCambridgeUK

Personalised recommendations

Cite article

Buy options